Class-Action Status Denied in Lilly Zyprexa Case - NYTimes.com
Links shared publicly online about this topic.
- 882total visits
Class-Action Status Denied in Lilly Zyprexa Case - NYTimes.com
A federal appeals court overturned a ruling that had granted class-action status in a case on Lilly's top-selling schizophrenia drug.
View full resource at nytimes.com
Tags: Bipolar Disorder Medication, Schizophrenia, Schizophrenia Medication, Drug, Zyprexa, Eli Lilly and Company, News
Most Recently Shared on September 11, 2010 at 5:30 am By:
News: Class-action status denied in case against Eli Lilly & Co. for improper marketing of the drug Zyprexa http://nyti.ms/doq4pq - #health
Advertisement
